BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23917652)

  • 21. Humoral immunity in polymyositis/dermatomyositis.
    Targoff IN
    J Invest Dermatol; 1993 Jan; 100(1):116S-123S. PubMed ID: 8423380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.
    Aggarwal R; Bandos A; Reed AM; Ascherman DP; Barohn RJ; Feldman BM; Miller FW; Rider LG; Harris-Love MO; Levesque MC; ; Oddis CV
    Arthritis Rheumatol; 2014 Mar; 66(3):740-9. PubMed ID: 24574235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires.
    Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF
    Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.
    Aggarwal R; Oddis CV; Goudeau D; Koontz D; Qi Z; Reed AM; Ascherman DP; Levesque MC
    Rheumatology (Oxford); 2016 Jun; 55(6):991-9. PubMed ID: 26888854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibody profiles in the sera of European patients with myositis.
    Brouwer R; Hengstman GJ; Vree Egberts W; Ehrfeld H; Bozic B; Ghirardello A; Grøndal G; Hietarinta M; Isenberg D; Kalden JR; Lundberg I; Moutsopoulos H; Roux-Lombard P; Vencovsky J; Wikman A; Seelig HP; van Engelen BG; van Venrooij WJ
    Ann Rheum Dis; 2001 Feb; 60(2):116-23. PubMed ID: 11156543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of myositis autoantibodies in Chinese patients with cancer-associated myositis.
    Li L; Liu C; Wang Q; Wu C; Zhang Y; Cheng L; Wen X; Zeng X; Zhang F; Li Y
    J Clin Lab Anal; 2020 Aug; 34(8):e23307. PubMed ID: 32222002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders.
    Gofrit SG; Yonath H; Lidar M; Shoenfeld Y; Kivity S
    Clin Rheumatol; 2018 May; 37(5):1257-1263. PubMed ID: 29453582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
    Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
    Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myositis-Specific Antibodies and Myositis-Associated Antibodies in Patients With Idiopathic Inflammatory Myopathies From the PANLAR Myositis Study Group.
    González-Bello Y; Garcia-Valladares I; Reyes-Pérez IV; García-Cerda D; Medrano-Ramírez G; Navarro-Zarza JE; Andrade-Ortega L; Maradiaga-Ceceña M; Cardenas-Anaya A; Nava-Zavala AH; Orozco-Barocio G; Vázquez-Del Mercado M; Rojo-Mejia A; Loyo E; Gottschalk P; Iglesias-Gamarra A; Vega K; Rojas C; Mantilla R; Gómez G; García-Kutzbach A; Fritzler MJ; García-De La Torre I
    J Clin Rheumatol; 2021 Dec; 27(8):e302-e306. PubMed ID: 32084069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.
    Aguila LA; Lopes MR; Pretti FZ; Sampaio-Barros PD; Carlos de Souza FH; Borba EF; Shinjo SK
    Clin Rheumatol; 2014 Aug; 33(8):1093-8. PubMed ID: 24989017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.
    Hamaguchi Y; Fujimoto M; Matsushita T; Kaji K; Komura K; Hasegawa M; Kodera M; Muroi E; Fujikawa K; Seishima M; Yamada H; Yamada R; Sato S; Takehara K; Kuwana M
    PLoS One; 2013; 8(4):e60442. PubMed ID: 23573256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis.
    Schiffenbauer A; Faghihi-Kashani S; O'Hanlon TP; Flegel WA; Adams SD; Targoff IN; Oddis CV; Ytterberg SR; Aggarwal R; Christopher-Stine L; Shamim EA; Dellaripa PF; Danoff SK; Mammen AL; Miller FW
    Semin Arthritis Rheum; 2018 Dec; 48(3):504-512. PubMed ID: 29703532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
    Sabbagh S; Pinal-Fernandez I; Kishi T; Targoff IN; Miller FW; Rider LG; Mammen AL;
    Ann Rheum Dis; 2019 Jul; 78(7):988-995. PubMed ID: 31018961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.
    Rönnelid J; Barbasso Helmers S; Storfors H; Grip K; Rönnblom L; Franck-Larsson K; Nordmark G; Lundberg IE
    Autoimmun Rev; 2009 Sep; 9(1):58-61. PubMed ID: 19285154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
    Yeker RM; Pinal-Fernandez I; Kishi T; Pak K; Targoff IN; Miller FW; Rider LG; Mammen AL;
    Ann Rheum Dis; 2018 May; 77(5):714-719. PubMed ID: 29363513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
    J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis.
    de Andrade VP; De Souza FHC; Behrens Pinto GL; Shinjo SK
    Adv Rheumatol; 2021 Feb; 61(1):12. PubMed ID: 33608062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.
    Kang EH; Nakashima R; Mimori T; Kim J; Lee YJ; Lee EB; Song YW
    BMC Musculoskelet Disord; 2010 Sep; 11():223. PubMed ID: 20875136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
    Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
    Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.